Login to Your Account

Agios Makes Strong Debut in Upsized IPO

By Jennifer Boggs
Managing Editor

Thursday, July 25, 2013

Continuing the trend of biotech's upsized initial public offerings (IPOs), Agios Pharmaceuticals Inc. bumped up both the number of shares offered and priced $2 above its proposed range for gross proceeds topping $106 million.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription